Akero Therapeutics, Inc.
2020 Q3 - 2025 Q2 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q2 | 8/14/2025 | 7,408 | 0.0% | 138,834 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 6,124 | 0.0% | 151,290 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 3,466 | 0.0% | 124,592 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 2,770 | 0.0% | 96,549 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 2,514 | 0.0% | 107,172 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 2,147 | 0.0% | 84,977 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 1,658 | 0.0% | 71,025 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 3,875 | 0.0% | 76,613 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 3,008 | 0.0% | 64,430 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 2,206 | 0.0% | 57,658 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 2,988 | 0.0% | 55,243 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 761 | 0.0% | 23,826 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 118 | 0.0% | 12,484 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 165 | 0.0% | 11,621 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 302 | 0.0% | 14,169 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 321 | 0.0% | 14,382 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 379 | 0.0% | 15,260 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 247 | 0.0% | 8,529 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 228 | 0.0% | 8,824 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 244 | 0.0% | 7,917 | 9/30/2020 |